These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 28033130)

  • 1. The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.
    McMullan CJ; Borgi L; Curhan GC; Fisher N; Forman JP
    J Hypertens; 2017 Apr; 35(4):822-829. PubMed ID: 28033130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial.
    Shroff R; Wan M; Gullett A; Ledermann S; Shute R; Knott C; Wells D; Aitkenhead H; Manickavasagar B; van't Hoff W; Rees L
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):216-23. PubMed ID: 22266572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Vitamin D on Endothelial Function: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Borgi L; McMullan C; Wohlhueter A; Curhan GC; Fisher ND; Forman JP
    Am J Hypertens; 2017 Feb; 30(2):124-129. PubMed ID: 28077419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
    McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
    Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional vitamin D supplementation in dialysis: a randomized trial.
    Bhan I; Dobens D; Tamez H; Deferio JJ; Li YC; Warren HS; Ankers E; Wenger J; Tucker JK; Trottier C; Pathan F; Kalim S; Nigwekar SU; Thadhani R
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):611-9. PubMed ID: 25770176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial.
    Miskulin DC; Majchrzak K; Tighiouart H; Muther RS; Kapoian T; Johnson DS; Weiner DE
    J Am Soc Nephrol; 2016 Jun; 27(6):1801-10. PubMed ID: 26677862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.
    Hammami MM; Abuhdeeb K; Hammami S; Yusuf A
    BMC Endocr Disord; 2019 Jan; 19(1):8. PubMed ID: 30658603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Suebthawinkul C; Panyakhamlerd K; Yotnuengnit P; Suwan A; Chaiyasit N; Taechakraichana N
    Climacteric; 2018 Oct; 21(5):491-497. PubMed ID: 30095022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: A randomized, double-blind clinical trial.
    Liyanage P; Lekamwasam S; Weerarathna TP; Liyanage C
    J Postgrad Med; 2018; 64(1):10-15. PubMed ID: 29386413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
    Carrara D; Bruno RM; Bacca A; Taddei S; Duranti E; Ghiadoni L; Bernini G
    J Hypertens; 2016 Nov; 34(11):2199-205. PubMed ID: 27648718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitamin D deficiency within a large integrated health care delivery system.
    Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
    J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
    Mueangpaisarn P; Chaiamnuay S
    Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
    Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
    Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
    Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO
    J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.
    Vaidya A; Sun B; Larson C; Forman JP; Williams JS
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2456-65. PubMed ID: 22539586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
    Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
    Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
    Fisk CM; Theobald HE; Sanders TA
    J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.